Leerink Revelation Partners Closes Second Fund at Hard Cap of $227 Million

June 12, 2018

BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--Jun 12, 2018--Leerink Revelation Partners (LRP), an investment partnership formed in 2015 between Leerink Capital Partners and Revelation Partners to provide capital and liquidity solutions to healthcare investors, funds, founders and companies, announced the closing of a second fund focused on secondary investments in healthcare. The new fund, Leerink Revelation Healthcare Fund II, was oversubscribed and closed at its hard cap of $227 million, surpassing its initial target of $200 million. The recent capital raise builds on the long-term success of the managing partners, Mr. Scott Halsted, Dr. Zack Scott and Mr. Mike Boggs, who have executed this secondary strategy for over ten years and who manage the $420 million of LRP capital.

In conjunction with the new capital raise, Fred Lee has joined the firm as Head of Business Origination. In this role, Fred will interface with emerging growth companies and healthcare investors to generate investment opportunities for LRP and enhance the firm’s industry relationships. Mr. Lee brings to LRP twelve years of experience in the healthcare financial services industry. Most recently, Mr. Lee worked at Bridge Bank as a Managing Director in the Life Sciences Group, where he was primarily responsible for originating venture debt investments in early to mid-stage life science companies and providing customized financing structures for both public and private companies. Prior to that, Mr. Lee worked at Capital One Healthcare as Vice President in the Life Science Finance group. He began his career at Citigroup Global Markets and held roles of increasing responsibility in the Healthcare Investment Banking team.

“We are pleased to announce the continued growth of Leerink Revelation Partners,” said Mr. Halsted, Founder and Managing Partner of Revelation Partners. “With the closing of our most recent fund, as well as the addition of Fred Lee to our team, we will continue to be one of the most active investors in the healthcare secondary market.”

Leerink Revelation Partners combines the experience and resources of Leerink Partners, a leading healthcare investment bank, and Revelation Partners’ established leadership in secondary transactions across healthcare. The investing team is based in San Francisco and invests broadly across healthcare sectors, focusing on commercial companies that have proven business models or companies with novel technologies that have clear clinical and regulatory pathways.

About Revelation Partners Revelation Partners is a San Francisco-based investment firm that invests in late-stage, private healthcare companies acquired in negotiated transactions from existing shareholders. We invest broadly across healthcare sectors with a focus on commercial companies with proven business models or companies with novel technologies that have clear clinical and regulatory pathways. We actively invest in the following healthcare verticals - medical devices, biopharmaceuticals, healthcare IT and healthcare services. For more information, please visit:  .

About Leerink Capital Partners Leerink Capital Partners LLC was formed in 2013 to build and lead a multi-strategy, healthcare-focused principal investment business with a dedicated team experienced in originating, structuring and managing healthcare investments. LCP leverages the healthcare expertise, proprietary analytics and insights, and deep industry relationships of its affiliate, Leerink Partners, a leading investment bank specializing in healthcare. For more information, please visit: .

About Leerink Partners Leerink Partners LLC is a leading investment bank, specializing in healthcare. Our knowledge, experience and focus enable us to help our clients define and achieve their strategic, capital markets and investment objectives. We partner with companies that develop and commercialize innovative products and services that are defining the future of healthcare. Leerink Partners LLC is a member of FINRA/SIPC. For more information, please visit:  .

View source version on businesswire.com:https://www.businesswire.com/news/home/20180612005158/en/

CONTACT: Leerink Revelation Partners

Scott Halsted, 415-905-7233


Weber Shandwick




SOURCE: Leerink Partners

Copyright Business Wire 2018.

PUB: 06/12/2018 12:00 PM/DISC: 06/12/2018 12:01 PM


Update hourly